What this case supports, and what it does not

This case supports a specimen-suitability call (short-filled EDTA aliquot, no clot, sterile aliquot protected), a corrected total nucleated cell count and differential consistent with an inflammatory pattern, and an MSU crystal identification built from needle shape, strong negative birefringence at two compensator orientations, and intracellular location. Each of those calls rests on a specific, documented observation, not on gross appearance or on a single field.

This case does not support a stand-alone diagnosis from color or viscosity, a universal cell-count cutoff for infection, or a conclusion that the pending culture is unnecessary. No US population-derived synovial fluid reference interval was used, because none was declared as applicable to this population; local validation controls report configuration and reference range. Basic calcium phosphate crystals were not evaluated, because they sit below what compensated polarized light can resolve; a negative examination for MSU and CPP is not evidence against basic calcium phosphate disease.

Method dependence matters here. Reagent lot, calibrator, control, microscope and compensator setup, cytocentrifuge settings, and software or procedure changes can each shift what a laboratory can defensibly claim, so the analyzer- and instrument-specific details are described in general terms rather than tied to one manufacturer's device. Federal test-system regulation requires a nonwaived laboratory to follow manufacturer instructions and its own established performance specifications for every test system it uses, which includes microscopy procedures with a defined local protocol.

Carry the specimen's limitations, the method's limitations, and the pending culture result forward on the report together, because a complete synovial fluid report tells the clinician what was found, how it was found, and what has not yet been ruled out.